All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

HCG in TRT: what a '10/10' rating actually tells us

Jacob Nach

TikTok creator

120.7K viewsWatch on TikTok→

Quick answer

HCG (human chorionic gonadotropin) acts as an LH analog to stimulate testicular testosterone production and maintain intratesticular testosterone, making it a clinically recognized tool for fertility preservation in TRT patients. The creator uses it daily as a standalone agent, which differs from standard protocols that typically use lower doses every other day or three times weekly. His claim of synergistic effects with enclomiphene reflects emerging off-label practice but involves two agents affecting the same hormonal axis without FDA-approved combined use data.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @jacobnach actually say?

Jacob made two core arguments. First, HCG can deliver "the physical and mental benefits of taking testosterone without shutting off your natural production," particularly when stacked with enclomiphene. Second, for men already on TRT, HCG is "the best compound on the planet" for preserving fertility. He rates his two-year daily HCG experience a perfect 10 out of 10 with zero drawbacks.

He's not selling anything outright, and he frames this as personal experience rather than medical advice. That's worth noting. But 120,000 people just watched a guy call HCG a side-effect-free perfect drug, and that framing deserves scrutiny regardless of intent.

Does the science back this up?

On the fertility claim, yes, mostly. On the "zero drawbacks" claim, no. The data here is real but incomplete in the way he presents it.

HCG mimics luteinizing hormone (LH) and directly stimulates testicular Leydig cells to produce testosterone and maintain intratesticular testosterone (ITT), which is essential for spermatogenesis. Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) demonstrated that low-dose HCG (500 IU every other day) alongside exogenous testosterone maintained ITT levels at approximately 25% of baseline, compared to near-zero in testosterone-only groups. That's a meaningful difference for fertility preservation.

The claim that HCG alone replicates TRT benefits without suppression is weaker. HCG does raise endogenous testosterone, but it also substantially raises estradiol due to increased aromatization in the testes. Ramasamy et al. (2014, BJU International) found men on HCG monotherapy often experienced elevated estradiol, which can cause gynecomastia, mood changes, and water retention. Those are drawbacks. Real ones.

What did they get wrong (or right)?

He got the fertility preservation mechanism right. That's legitimate science, not bro-science. Men on TRT who add HCG do have meaningfully better outcomes for sperm production than those who don't. Credit where it's due.

What he got wrong is the "no drawbacks" framing. HCG's primary liability is estrogen conversion. Because HCG stimulates testicular testosterone production at the source, the aromatase activity in testicular tissue converts a portion of that testosterone to estradiol. This is not a minor footnote. Liu et al. (2009, Journal of Clinical Endocrinology and Metabolism) specifically noted estradiol elevation as a consistent finding in HCG-treated hypogonadal men.

He also implies HCG plus enclomiphene is a low-risk, high-reward stack for anyone wanting testosterone benefits without suppression. Enclomiphene is not FDA-approved and is being used off-label here. Stacking two agents that both raise LH signaling introduces complexity he doesn't address at all.

  • HCG fertility preservation claim: accurate and well-supported
  • "Zero drawbacks" claim: inaccurate, estradiol elevation is documented
  • HCG plus enclomiphene stack presented without risk context: misleading by omission

What should you actually know?

If you're on TRT and want to maintain fertility, the evidence genuinely supports adding HCG. That part of this video is directionally correct. But "no drawbacks" is not a thing that exists in pharmacology, and anyone presenting it that way is either very lucky or not paying close enough attention to their labs.

A few things this video doesn't mention: HCG requires injection, is temperature-sensitive, and is not available over the counter. Compounded HCG and pharmaceutical HCG are different products, and the FDA withdrew approval of compounded HCG in 2020, creating a complicated regulatory environment for access. Kisspeptin analogs and gonadorelin are increasingly used in similar protocols, partly for this reason.

Two years of subjective experience with no bloodwork shown is not a clinical trial. Absence of perceived side effects is not the same as absence of side effects. Anyone considering HCG should have baseline and follow-up labs including total testosterone, free testosterone, estradiol, LH, FSH, and a semen analysis if fertility is the goal.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For HCG in TRT: what a '10/10' rating actually tells us, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

HCG in TRT: what a '10/10' rating actually tells us is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

HCG (human chorionic gonadotropin) acts as an LH analog to stimulate testicular testosterone production and maintain intratesticular testosterone, making it a clinically recognized tool for fertility preservation in TRT patients.

FormBlends verdict

HCG (human chorionic gonadotropin) acts as an LH analog to stimulate testicular testosterone production and maintain intratesticular testosterone, making it a clinically recognized tool for fertility preservation in TRT patients. The creator uses it daily as a standalone agent, which differs from standard protocols that typically use lower doses every other day or three times weekly. His claim of synergistic effects with enclomiphene reflects emerging off-label practice but involves two agents affecting the same hormonal axis without FDA-approved combined use data.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • HCG (human chorionic gonadotropin) acts as an LH analog to stimulate testicular testosterone production and maintain intratesticular testosterone, making it a clinically recognized tool for fertility preservation in TRT patients. The creator uses it daily as a standalone agent, which differs from standard protocols that typically use lower doses every other day or three times weekly. His claim of synergistic effects with enclomiphene reflects emerging off-label practice but involves two agents affecting the same hormonal axis without FDA-approved combined use data.
  • Coviello et al. (2005, JCEM) found 500 IU HCG every other day maintained intratesticular testosterone at ~25% of baseline in men on exogenous testosterone, supporting its use for fertility preservation.
  • HCG raises estradiol through testicular aromatization. Liu et al. (2009, JCEM) documented consistent estradiol elevation in HCG-treated hypogonadal men, making the 'zero drawbacks' claim unsupported by the literature.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Coviello et al. (2005, JCEM) found 500 IU HCG every other day maintained intratesticular testosterone at ~25% of baseline in men on exogenous testosterone, supporting its use for fertility preservation.
  • HCG raises estradiol through testicular aromatization. Liu et al. (2009, JCEM) documented consistent estradiol elevation in HCG-treated hypogonadal men, making the 'zero drawbacks' claim unsupported by the literature.
  • The FDA withdrew approval for compounded HCG in 2020, creating access complications. Gonadorelin is increasingly used as an alternative in TRT protocols for similar LH-mimicking effects.
  • Enclomiphene is not FDA-approved and its combination with HCG has no published controlled trial data. Stacking both without clinical oversight is not a low-risk move despite how it's framed here.
  • Chronic high-dose HCG use carries risk of Leydig cell desensitization to LH, potentially reducing its own effectiveness over time, a dynamic not addressed in this two-year personal-experience report.
  • Anyone using HCG for fertility preservation should track estradiol, FSH, LH, and semen analysis alongside testosterone levels. Subjective wellbeing alone is not sufficient monitoring.
  • HCG monotherapy can raise testosterone meaningfully in men with intact testicular function, but average increases are generally lower and more variable than exogenous testosterone, per Ramasamy et al. (2014, BJU International).

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Jacob Nach · TikTok creator

120.7K views on this video

Can’t say enough good about HCG our first ever 10/10🏆

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Jacob Nach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.